Full history for every metric is available with a Kvantra account
Key financial summary
Financials in SGDTTM unavailable because four recent quarterly reports are not available| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | SGD m | - | - | - | - | - | - | - |
| Operating profit | SGD m | - | ||||||
| Net profit | SGD m | - | - | - | - | - | - | - |
| EPS reported | SGD | - | ||||||
| Operating cashflow per share | SGD | - | ||||||
| Capex per share | SGD | - | ||||||
| FCF per share | SGD | - | ||||||
| Free cash flow | SGD m | - | ||||||
| Net debt | SGD m | - | ||||||
| Book value equity | SGD m | - | ||||||
| Book value per share | SGD | - | ||||||
| Number of shares | m | - | ||||||
| DPS (TTM paid) | SGD | - |
Financial summary
Financials in SGDTTM unavailable because four recent quarterly reports are not available| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | ||||||
| P/B LTM | x | - | ||||||
| P/S LTM | x | - | ||||||
| P/FCF LTM | x | - | ||||||
| EV/EBITDA LTM | x | - | ||||||
| EV/Sales LTM | x | - | ||||||
| Earnings Yield LTM | % | - | ||||||
| FCF Yield | % | - | ||||||
| Quality | ||||||||
| ROE | % | - | ||||||
| ROIC | % | - | ||||||
| Operating margin | % | - | ||||||
| Gross margin | % | - | ||||||
| FCF/Sales | % | - | ||||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | ||||||
| Sales Growth YoY | % | - | ||||||
| Net Income Growth YoY | % | - | ||||||
| FCF Growth | % | - | ||||||
| Operating Profit Growth | % | - | ||||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | - | ||||||
| Dividend Growth | % | - | ||||||
| Payout Ratio | % | - | ||||||
| FCF/Debt | x | - | ||||||
| Net Debt/EBITDA | x | - | ||||||
| EBIT/Net interest | x | - | ||||||
| Net debt/market cap | % | - | ||||||
| Net debt/Equity | x | - | ||||||
| Gross debt/equity | x | - | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Beverly Wilshire Ltd., an investment holding company, provides aesthetic medical and healthcare services in Singapore and Malaysia. It operates in three segments: Aesthetic Medical and Healthcare; Trading and Distribution; and Investment and Others. The Aesthetic Medical and Healthcare segment offers aesthetic medical, beauty, and wellness services. The Trading and Distribution segment engages in the trading and distribution of steel raw materials, consumables, instruments, and semi-finished products for steel mills, iron and steel foundries, and aluminum smelters in the Asia-Pacific region, as well as the provision of ancillary services. The Investment and Others segment provides management, marketing, distribution, and related services. The company also operates beauty and wellness medical centers that provide cosmetic and plastic surgery, aesthetic and reconstructive surgery, cosmetological and aesthetic-related treatments, health screening, dental aesthetics, hair restoration and transplant care, and a range of healthy aging and wellness services; medical specialist centers with outpatient and day care services and activities; and beauty salons and spas. In addition, the company offers medical research, physiotherapy, and reflexology services. The company was formerly known as Beverly JCG Ltd. and changed its name to Beverly Wilshire Ltd. in September 2025. Beverly Wilshire Ltd. was founded in 1987 and is headquartered in Singapore.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Beverly Wilshire Ltd., an investment holding company, provides aesthetic medical and healthcare services in Singapore and Malaysia. It operates in three segments: Aesthetic Medical and Healthcare; Trading and Distribution; and Investment and Others. The Aesthetic Medical and Healthcare segment offers aesthetic medical, beauty, and wellness services. The Trading and Distribution segment engages in the trading and distribution of steel raw materials, consumables, instruments, and semi-finished products for steel mills, iron and steel foundries, and aluminum smelters in the Asia-Pacific region, as well as the provision of ancillary services. The Investment and Others segment provides management, marketing, distribution, and related services. The company also operates beauty and wellness medical centers that provide cosmetic and plastic surgery, aesthetic and reconstructive surgery, cosmetological and aesthetic-related treatments, health screening, dental aesthetics, hair restoration and transplant care, and a range of healthy aging and wellness services; medical specialist centers with outpatient and day care services and activities; and beauty salons and spas. In addition, the company offers medical research, physiotherapy, and reflexology services. The company was formerly known as Beverly JCG Ltd. and changed its name to Beverly Wilshire Ltd. in September 2025. Beverly Wilshire Ltd. was founded in 1987 and is headquartered in Singapore.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free